← Research library

Stemokin in treatment and prevention of pyoderma in military personnel

Comparison in people · 2015

What was studied
Treatment comparison: 39 adjunctive Stemokin versus 37 basic care; prevention comparison: 40 versus 36. Participant overlap unresolved.
Main finding
The report compares adjunctive treatment in groups of 39 and 37, and prevention in groups of 40 and 36. Reported recovery was 74.36% versus 21.62%; reported infection incidence was 17.5% versus 58.3% during follow-up up to 12 months. Allocation and blinding are unclear. The 2011 dissertation appears to report overlapping groups; neither publications nor the two investigations establish 152 unique participants.

Related evidence maps: Military & occupational ↗

Reported findings and study design

Population or model Treatment comparison: 39 adjunctive Stemokin versus 37 basic care; prevention comparison: 40 versus 36. Participant overlap unresolved.

Results · Results from an indexed excerpt of the original conference abstract. The full abstract was unavailable from the host.
MeasureResultComparison, timing and statistics
Reported clinical recovery in the adjunct-treatment arm74.36% among 39 treated participants
Reported pyoderma incidence in the prevention arm17.5% among 40 participants over follow-up up to 12 months

These arm-level proportions are not causal effect estimates. The excerpt gives no percentages for the comparison group. Allocation, blinding and overlap between the treatment and prevention groups remain unresolved; the reports may count some participants more than once.

Source for these results ↗ · Reviewed 2026-11-05

Study limitations and source details

Study limitations

  • Independent replication and full risk-of-bias appraisal remain unresolved.
  • No personalized treatment or safety conclusion follows from this record.

Source details

Conference abstract

Indexed original abstract passages rechecked; direct host access returned 403. Reported active-arm recovery and prevention proportions recovered; full dissertation appraisal pending.

Sources checked

Citation

Human comparative studyRussian-language source

V. V. Gladko, N. N. Kakhishvili, S. A. Masyukova. Stemokin in treatment and prevention of pyoderma in military personnel Conference abstract on Dermatology in Russia, posted 25 January 2015; underlying study dates unresolved

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards